A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity.

about

Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity.An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer.

P2860

Q33641923-91A80ED0-AB8D-4D13-A0E1-551DA38E5716 Q37013285-B2073066-BE2B-4205-83AA-8D79DE214DBA

P2860

A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity.

Item

http://www.wikidata.org/entity/Q38845355

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A novel humanized anti-HER2 an ...... ts potent anti-tumor activity.

@en

type

Item

label

A novel humanized anti-HER2 an ...... ts potent anti-tumor activity.

@en

prefLabel

A novel humanized anti-HER2 an ...... ts potent anti-tumor activity.

@en

P1476

A novel humanized anti-HER2 an ...... ts potent anti-tumor activity.

@en

P2093

Changjiang Huang

http://www.w3.org/2001/XMLSchema#string

Dong Li

http://www.w3.org/2001/XMLSchema#string

Hongwen Li

http://www.w3.org/2001/XMLSchema#string

Jianmin Fang

http://www.w3.org/2001/XMLSchema#string

Jing Jiang

http://www.w3.org/2001/XMLSchema#string

Kuan Xie

http://www.w3.org/2001/XMLSchema#string

Liguang Lou

http://www.w3.org/2001/XMLSchema#string

Qiaoyu Xu

http://www.w3.org/2001/XMLSchema#string

Xin Wang

http://www.w3.org/2001/XMLSchema#string

Xuejing Yao

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody-drug conjugates of calicheamicin derivative: gemtuzumab ozogamicin and inotuzumab ozogamicin

Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies.

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate.

Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides.

P2888

s10549-015-3503-3

P304

123-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-015-3503-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1040244288

http://www.w3.org/2001/XMLSchema#string

P698

26253944

http://www.w3.org/2001/XMLSchema#string

A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity.

about

P2860

P2860

A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698